Buy Opana ER 5mg in UK Online

Opana ER 5mg is an extended-release (ER) formulation of oxymorphone hydrochloride, a strong opioid pain medicine used in some countries for the management of severe, long-term pain that requires around-the-clock opioid treatment. The extended-release formulation is designed to release oxymorphone slowly over approximately 12 hours and is not intended for occasional or breakthrough pain. (MedlinePlus)

For readers in the United Kingdom, it is important to know that Opana ER is not licensed or routinely prescribed in the UK. In addition, the original Opana ER brand was withdrawn from the U.S. market after concerns about public health consequences related to misuse and abuse. (Drugs.com)

What Is Opana ER 5mg?

Opana ER 5mg contains:

• Active ingredient: Oxymorphone hydrochloride
• Strength: 5 mg
• Medicine class: Strong opioid (opioid analgesic)
• Dosage form: Extended-release tablet

Oxymorphone is a semi-synthetic opioid that acts on opioid receptors in the brain and spinal cord to reduce the perception of pain.

How Does It Work?

Oxymorphone binds primarily to mu-opioid receptors, reducing the transmission of pain signals and changing how the brain responds to pain.

This may help:

• Reduce severe chronic pain
• Improve physical function in some patients
• Improve comfort when other pain treatments have not been effective

Because it acts on the central nervous system, it can also cause drowsiness and slow breathing.

Medical Uses

Where licensed, Opana ER has been used for adults with pain that:

• Is severe enough to require continuous opioid treatment
• Is expected to last for an extended period
• Cannot be adequately controlled with non-opioid medicines or other treatments

It is not intended for:

• Mild pain
• Short-term pain
• Pain after minor injuries
• “As needed” pain relief

Availability in the UK

Opana ER is not routinely available or prescribed in the United Kingdom. UK clinicians who determine that long-acting opioid therapy is appropriate generally prescribe other medicines that are licensed for UK use, depending on the patient’s condition and medical history. (Drugs.com)

How Should It Be Taken?

If prescribed in countries where it is available:

• Take it exactly as directed by your healthcare professional.
• Swallow the tablet whole with water.
• Do not crush, chew, split, or dissolve the tablet.

Damaging an extended-release tablet can release the full dose at once, greatly increasing the risk of overdose. (MedlinePlus)

Common Side Effects

Like other opioid medicines, oxymorphone may cause:

• Constipation
• Nausea
• Vomiting
• Drowsiness
• Dizziness
• Headache
• Dry mouth
• Sweating

Constipation is particularly common and may require dietary measures or other treatments recommended by a healthcare professional.

Serious Side Effects

Seek emergency medical attention if someone develops:

• Difficulty breathing
• Very slow or shallow breathing
• Extreme sleepiness or inability to wake
• Blue lips or fingertips
• Loss of consciousness
• Severe allergic reaction

These symptoms may indicate an opioid overdose or another life-threatening emergency. (MedlinePlus)

Dependence, Tolerance, and Addiction

Oxymorphone carries significant risks of:

• Tolerance, where higher doses may eventually be needed for the same effect.
• Physical dependence, where stopping suddenly can lead to withdrawal symptoms.
• Opioid use disorder (addiction) in some individuals.

For people who have taken opioids regularly, treatment should generally be reduced gradually under medical supervision rather than stopped abruptly.

Drug Interactions

Oxymorphone may interact with:

• Other opioid medicines
• Benzodiazepines
• Sleeping tablets
• Alcohol
• Certain muscle relaxants
• Other medicines that cause drowsiness

These combinations can increase the risk of profound sedation, respiratory depression, coma, and death.

Alcohol

Alcohol should be avoided while taking opioid medicines because it can substantially increase the risk of severe drowsiness, dangerously slowed breathing, and overdose.

Driving

Do not drive or operate machinery if oxymorphone causes:

• Sleepiness
• Dizziness
• Poor concentration
• Slowed reaction times

Driving while impaired by opioid medicines is unsafe and may be illegal.

Pregnancy and Breastfeeding

If you are pregnant, planning pregnancy, or breastfeeding, discuss opioid treatment with your healthcare professional. Long-term opioid use during pregnancy may cause withdrawal symptoms in the newborn after birth.

Storage

Store opioid medicines:

• In their original packaging.
• At room temperature.
• Away from moisture and heat.
• Securely and out of the sight and reach of children.

Unused tablets should be returned to a pharmacy for safe disposal.

Frequently Asked Questions

Is Opana ER 5 mg available in the UK?

No. Opana ER is not licensed or routinely prescribed in the UK. (Drugs.com)

Can Opana ER be used for sudden pain?

No. Extended-release oxymorphone is intended for continuous management of severe chronic pain, not occasional or breakthrough pain. (MedlinePlus)

Can the tablet be crushed?

No. Extended-release tablets must be swallowed whole. Crushing, chewing, or splitting them can release the full dose rapidly and significantly increase the risk of overdose. (MedlinePlus)

Is the Opana ER brand still marketed?

No. The original Opana ER brand has been discontinued and withdrawn from the U.S. market, although some generic oxymorphone products may still exist in certain markets. (Drugs.com)

Key Takeaways

Opana ER 5 mg is an extended-release oxymorphone tablet developed for the long-term treatment of severe pain requiring continuous opioid therapy. It is not available as a routine treatment in the UK, and the original Opana ER brand has been discontinued. Like all strong opioids, it carries important risks, including constipation, drowsiness, respiratory depression, dependence, addiction, and overdose. If opioid therapy is needed, it should be used only under the close supervision of a qualified healthcare professional, at the lowest effective dose and with regular review. (Drugs.com)